In contrast, ERFE directly suppresses hepcidin production in order to facilitate iron mobilization, which is particularly relevant in SCA patients, who may suffer from both anaemia and increased iron demand due to chronic blood destruction [18, 19]. This evidence concerns the gene HAMP and anemia (phenotype).